GB202211274D0 - Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction - Google Patents

Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Info

Publication number
GB202211274D0
GB202211274D0 GBGB2211274.2A GB202211274A GB202211274D0 GB 202211274 D0 GB202211274 D0 GB 202211274D0 GB 202211274 A GB202211274 A GB 202211274A GB 202211274 D0 GB202211274 D0 GB 202211274D0
Authority
GB
United Kingdom
Prior art keywords
diseases
treatment
conditions associated
flavonoid compound
neurodegenerative dysfunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2211274.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ontrack Therapeutics Ltd
Original Assignee
Ontrack Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ontrack Therapeutics Ltd filed Critical Ontrack Therapeutics Ltd
Publication of GB202211274D0 publication Critical patent/GB202211274D0/en
Ceased legal-status Critical Current

Links

GBGB2211274.2A 2022-05-24 2022-08-02 Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction Ceased GB202211274D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2207558.4A GB202207558D0 (en) 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Publications (1)

Publication Number Publication Date
GB202211274D0 true GB202211274D0 (en) 2022-09-14

Family

ID=82220586

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB2207558.4A Ceased GB202207558D0 (en) 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
GBGB2211274.2A Ceased GB202211274D0 (en) 2022-05-24 2022-08-02 Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB2207558.4A Ceased GB202207558D0 (en) 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Country Status (1)

Country Link
GB (2) GB202207558D0 (en)

Also Published As

Publication number Publication date
GB202207558D0 (en) 2022-07-06

Similar Documents

Publication Publication Date Title
IL288214A (en) Quinazolin-4-one derivatives useful for the treatment of braf-associated diseases and disorders
IL289167A (en) 2h-indazole derivatives and their use in the treatment of disease
ZA202006234B (en) Compositions and methods for the treatment of neurological diseases
IL288882A (en) Mixture of plant extracts for use in the prevention and/or treatment of chronic inflammatory bowel diseases
EP3639833A4 (en) Agent for the prevention or treatment of fat-related diseases and/or inflammation
IL284125A (en) Quinoline derivatives for use in the treatment of inflammation diseases
IL287796A (en) Compositions and methods for the treatment of atpase-mediated diseases
EP4054713A4 (en) Compositions and methods for treatment or prevention of skin diseases and disorders with lekti
IL272253A (en) Compositions and methods for treatment of inflammatory conditions and diseases of the skin
EP3913002A4 (en) Application of ecm1 in prevention and/or treatment of liver fibrosis-related diseases
EP3801587A4 (en) Acylated catechin polyphenols and methods of their use for the treatment of cancer
GB202211274D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
GB202207556D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
PT3937948T (en) Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases
EP4087847A4 (en) Compositions and methods for the treatment of neurodegenerative diseases
EP4100127A4 (en) Methods for the treatment of scleroderma and related conditions
IL290192A (en) Nitenin analogue compounds and their use in the treatment of chronic and acute pain
EP4073113A4 (en) Therapeutic compositions comprising an amyloid beta antibody or vaccine for prevention and treatment of diastolic dysfunction
IL282718A (en) Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity
GB202304262D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders
GB202207559D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders
EP3917619A4 (en) Structurally modified opioids for prevention and treatment of diseases and conditions
GB202217453D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity
GB202208255D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity
GB202208256D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)